ENXTAM:DSFIRChemicals
DSM-Firmenich (ENXTAM:DSFIR): Assessing Valuation as Drug Delivery Innovations Take the Spotlight at PODD
DSM-Firmenich (ENXTAM:DSFIR) is set to present at the upcoming Partnership Opportunities in Drug Delivery (PODD) conference in Boston. Investors are watching closely, interested in potential updates on innovative drug delivery technologies.
See our latest analysis for DSM-Firmenich.
DSM-Firmenich’s scheduled appearance at PODD comes after a tough run for investors, with the 1-year total shareholder return sliding 33.9%. Recent momentum has faded, and shares sit at €69.8, reflecting a 28%...